Parag Kolhe is Senior director at Pfizer biotherapeutic pharmaceutical sciences and co-leads formulation and process development group responsible for development of biotherapeutics modalities. His expertise is in the area of biologics formulation, process development, tech transfer, PPQ and control strategy approaches. He has broad product development knowledge ranging from early stage to commercial life cycle management products. He has developed various biologics modalities ranging from monoclonal antibodies, antibody drug conjugates, vaccines and more recently Chimeric Antigen T Cell therapy and gene therapy. holds PhD in Chemical Engineering and material science from Wayne State University.